What is Limoneira's operating income?

Limoneira's total operating income in 2025 was -$20.41 million, based on the following breakdown: Total Gross Profit: $4.91 million Total Operating Expenses: $25.32 million

Limoneira (LMNR) Financials

$13.11 -0.17 (-1.28%)

Closing price 04:00 PM Eastern

Extended Trading

$13.09 -0.02 (-0.15%)

As of 07:34 PM Eastern

Compare

Annual Income Statements for Limoneira

This table shows Limoneira's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Net Income / (Loss) Attributable to Common Shareholders	6.45	7.43	6.04	20	-6.44	-17	-3.94	-0.74	8.90	7.22	-16
Consolidated Net Income / (Loss)	7.08	8.06	6.55	20	-5.47	-18	-3.90	-0.47	9.12	7.17	-16
Net Income / (Loss) Continuing Operations	7.08	8.06	6.55	20	-5.47	-18	-3.90	-0.47	9.12	7.17	-16
Total Pre-Tax Income	11	13	11	13	-6.56	-26	-4.16	0.35	13	12	-21
Total Operating Income	4.58	9.19	12	9.49	-5.51	-19	-6.33	2.20	11	-6.18	-20
Total Gross Profit	23	26	30	31	19	7.28	18	24	11	27	4.91
Total Revenue	100	112	121	129	171	165	166	185	180	192	160
Operating Revenue	100	112	121	129	171	165	166	185	180	192	160
Total Cost of Revenue	77	86	91	98	152	157	148	161	169	165	155
Operating Cost of Revenue	77	86	91	98	152	157	148	161	169	165	155
Total Operating Expenses	19	17	18	22	25	26	24	22	-0.05	33	25
Selling, General & Admin Expense	14	13	14	16	21	21	19	22	26	27	24
Other Operating Expenses / (Income)	4.77	3.62	3.93	4.21	4.44	4.50	4.33	4.44	4.61	5.27	0.14
Impairment Charge	0.00	0.00	0.12	1.56	-	-	-	0.00	0.00	0.64	0.00
Other Special Charges / (Income)	-	-	0.00	0.00	-1.07	0.50	0.11	-4.50	-31	-0.51	0.71
Total Other Income / (Expense), net	6.47	4.14	-1.24	4.00	-1.05	-7.43	2.17	-1.85	2.58	18	-0.60
Interest Expense	0.15	1.41	1.78	1.32	2.34	2.05	1.50	2.29	0.49	0.96	1.55
Interest & Investment Income	0.24	0.63	0.05	0.78	3.28	0.70	3.58	1.39	5.69	18	0.86
Other Income / (Expense), net	6.38	4.91	0.49	4.54	-1.99	-6.08	0.09	-0.96	-2.61	0.21	0.09
Income Tax Expense	3.97	5.27	4.08	-6.73	-1.10	-8.49	-0.27	0.82	4.25	4.37	-4.65
Preferred Stock Dividends Declared	0.64	0.63	0.56	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	-0.05	0.02	0.48	-1.51	-0.46	-0.24	-0.28	-0.54	-0.38
Basic Earnings per Share	$0.46	$0.52	$0.42	$1.26	($0.37)	($0.96)	($0.23)	($0.04)	$0.50	$0.40	($0.93)
Weighted Average Basic Shares Outstanding	14.12M	14.17M	14.32M	15.58M	17.58M	17.67M	17.56M	17.51M	17.60M	17.72M	17.83M
Diluted Earnings per Share	$0.46	$0.52	$0.42	$1.25	($0.37)	($0.96)	($0.23)	($0.04)	$0.50	$0.40	($0.93)
Weighted Average Diluted Shares Outstanding	14.12M	14.17M	14.32M	16.21M	17.58M	17.67M	17.56M	17.51M	17.60M	17.72M	17.83M
Weighted Average Basic & Diluted Shares Outstanding	14M	14.30M	14.40M	15.60M	17.40M	17.65M	17.70M	17.68M	17.99M	18.08M	18.12M
Cash Dividends to Common per Share	$0.18	$0.20	$0.22	$0.25	$0.30	$0.30	$0.30	$0.30	$0.30	$0.30	$0.30

This table shows Limoneira's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-3.58	-3.71	6.44	6.47	-1.98	-3.20	-3.49	-0.98	-8.82	-9.55	-21
Consolidated Net Income / (Loss)	-3.54	-3.68	6.56	6.22	-1.92	-3.07	-3.37	-0.92	-9.00	-9.31	-22
Net Income / (Loss) Continuing Operations	-3.54	-3.68	6.56	6.22	-1.92	-3.07	-3.37	-0.92	-9.00	-9.31	-22
Total Pre-Tax Income	-4.83	-7.87	12	9.24	-1.60	-5.48	-3.06	-0.73	-12	-12	-28
Total Operating Income	-9.69	-7.75	-4.68	8.99	-2.75	-5.35	-3.35	-0.63	-11	-11	-22
Total Gross Profit	-1.46	0.62	4.17	18	4.04	0.81	3.42	5.43	-4.74	-4.81	0.77
Total Revenue	41	40	45	63	44	34	35	47	43	18	24
Operating Revenue	41	40	45	63	44	34	35	47	43	18	24
Total Cost of Revenue	43	39	40	45	40	33	32	42	48	23	23
Operating Cost of Revenue	43	39	40	45	40	33	32	42	48	23	23
Total Operating Expenses	8.23	8.36	8.85	8.88	6.79	6.15	6.76	6.06	6.35	5.74	22
Selling, General & Admin Expense	6.55	7.35	7.37	6.99	5.76	6.48	5.73	4.96	7.31	4.59	5.42
Other Operating Expenses / (Income)	1.33	1.18	1.43	1.25	1.41	-0.32	1.03	1.09	-1.64	1.07	7.72
Impairment Charge	-	-	-	0.64	-	-	0.00	0.00	-	-	9.32
Total Other Income / (Expense), net	4.86	-0.12	16	0.24	1.15	-0.13	0.28	-0.10	-0.65	-1.46	-5.91
Interest Expense	0.08	0.21	0.35	0.27	0.13	0.26	0.23	0.41	0.66	0.78	0.56
Interest & Investment Income	4.92	0.06	17	0.51	1.30	0.12	0.50	0.30	-0.06	0.18	-0.27
Other Income / (Expense), net	0.02	0.02	0.20	0.01	-0.01	0.01	0.01	0.01	0.07	-0.86	-5.08
Income Tax Expense	-1.29	-4.19	5.22	3.02	0.32	-2.41	0.30	0.18	-2.73	-2.70	-5.28
Preferred Stock Dividends Declared	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.08	-0.09	-0.01	-0.38	-0.06	0.00	-0.00	-0.06	-0.31	0.11	-0.90
Basic Earnings per Share	($0.20)	($0.21)	$0.36	$0.36	($0.11)	($0.18)	($0.20)	($0.06)	($0.49)	($0.53)	($1.20)
Weighted Average Basic Shares Outstanding	17.60M	17.63M	17.71M	17.76M	17.72M	17.79M	17.83M	17.85M	17.83M	17.91M	17.93M
Diluted Earnings per Share	($0.17)	($0.21)	$0.35	$0.35	($0.09)	($0.18)	($0.20)	($0.06)	($0.49)	($0.53)	($1.20)
Weighted Average Diluted Shares Outstanding	17.60M	17.63M	18.36M	18.36M	17.72M	17.79M	17.83M	17.85M	17.83M	17.91M	17.93M
Weighted Average Basic & Diluted Shares Outstanding	17.99M	18.00M	18.01M	18.05M	18.08M	18.05M	18.07M	18.05M	18.12M	18.11M	18.13M

This table details how cash moves in and out of Limoneira's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Net Change in Cash & Equivalents	-0.05	-0.00	0.45	0.12	0.01	-0.12	-0.06	-1.99	2.77	-0.64	-1.49
Net Cash From Operating Activities	7.70	14	18	18	1.37	-11	9.61	15	-16	18	-6.01
Net Cash From Continuing Operating Activities	7.70	14	18	18	1.37	-11	9.61	12	-16	18	-6.01
Net Income / (Loss) Continuing Operations	7.08	8.06	6.55	20	-5.47	-18	-3.90	-0.47	9.12	7.17	-16
Consolidated Net Income / (Loss)	7.08	8.06	6.55	20	-5.47	-18	-3.90	-0.47	9.12	7.17	-16
Depreciation Expense	4.18	5.34	6.47	7.28	8.63	10	9.81	9.80	8.58	8.37	9.21
Non-Cash Adjustments To Reconcile Net Income	-3.87	-3.30	2.39	-4.50	-0.28	9.65	0.56	-3.09	-29	2.73	11
Changes in Operating Assets and Liabilities, net	0.25	4.15	2.99	-4.59	-1.53	-13	3.13	5.86	-4.42	-0.43	-9.58
Net Cash From Investing Activities	-26	-12	-26	-51	-24	3.85	-10	19	91	-9.19	-18
Net Cash From Continuing Investing Activities	-26	-12	-26	-51	-24	3.85	-10	19	91	-9.19	-18
Purchase of Property, Plant & Equipment	-31	-16	-13	-14	-16	-11	-9.83	-10	-10	-9.41	-14
Acquisitions	-3.40	-18	-13	-3.50	-19	-2.80	0.00	-0.05	-0.85	-0.69	-6.85
Purchase of Investments	-0.30	-0.30	-0.36	-25	-0.47	-1.86	-0.65	-0.51	-0.52	-0.53	-0.51
Sale of Property, Plant & Equipment	2.71	0.00	0.00	1.54	6.86	6.26	0.12	27	101	1.04	0.41
Sale and/or Maturity of Investments	6.43	4.02	0.00	4.92	5.22	13	0.13	2.76	0.16	0.28	0.37
Other Investing Activities, net	-	-	-	-15	-0.40	0.00	0.00	0.12	0.98	0.12	1.78
Net Cash From Financing Activities	18	-2.78	8.38	33	22	7.36	0.53	-34	-72	-9.29	23
Net Cash From Continuing Financing Activities	18	-2.78	8.38	33	22	7.36	0.53	-34	-72	-9.29	23
Repayment of Debt	-99	-156	-169	-194	-94	-104	-95	-174	-123	-176	-138
Payment of Dividends	-3.17	-3.46	-3.72	-4.53	-5.83	-5.86	-5.80	-5.82	-5.88	-5.91	-5.92
Issuance of Debt	120	157	181	167	123	121	102	147	58	176	170
Other Financing Activities, net	-0.24	-0.28	-0.29	-0.66	-0.61	-0.21	-0.72	-0.89	-1.06	-3.01	-2.98
Effect of Exchange Rate Changes	0.00	0.00	0.01	-0.02	-0.14	-0.01	0.04	-	-0.01	-0.01	0.03
Cash Interest Paid	0.06	1.41	1.64	1.59	2.53	1.87	1.50	2.06	0.65	0.97	1.19
Cash Income Taxes Paid	2.96	2.13	-0.54	0.21	0.13	-1.24	-5.91	0.08	7.23	5.19	0.71

This table details how cash moves in and out of Limoneira's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
Net Change in Cash & Equivalents	-11	-3.10	0.88	-0.31	1.91	-1.86	0.95	0.03	-0.60	-0.24	-0.38
Net Cash From Operating Activities	-3.28	-10	-3.02	25	6.59	-13	8.93	-2.97	0.94	-12	-4.47
Net Cash From Continuing Operating Activities	-7.12	-10	-3.02	25	6.59	-13	8.93	-2.97	0.94	-12	-4.47
Net Income / (Loss) Continuing Operations	-3.54	-3.68	6.56	6.22	-1.92	-3.07	-3.37	-0.92	-9.00	-9.31	-22
Consolidated Net Income / (Loss)	-3.54	-3.68	6.56	6.22	-1.92	-3.07	-3.37	-0.92	-9.00	-9.31	-22
Depreciation Expense	2.07	2.06	2.10	2.12	2.10	2.02	2.11	2.48	2.60	2.16	2.01
Non-Cash Adjustments To Reconcile Net Income	-6.82	1.08	-15	17	-0.18	-0.19	11	1.00	-0.75	0.34	24
Changes in Operating Assets and Liabilities, net	1.16	-9.73	3.31	-0.59	6.59	-12	-0.46	-5.54	8.10	-4.93	-7.98
Net Cash From Investing Activities	-1.78	-1.64	-1.28	-3.76	-2.50	-3.49	-3.01	-3.35	-8.49	-3.41	-0.01
Net Cash From Continuing Investing Activities	-0.93	-1.64	-1.28	-3.76	-2.50	-3.49	-3.01	-3.35	-8.49	-3.41	-0.01
Purchase of Property, Plant & Equipment	-1.35	-2.24	-1.47	-3.01	-2.69	-4.08	-2.40	-3.14	-3.92	-3.02	-4.99
Acquisitions	-0.57	-0.29	0.07	-0.31	-0.17	-0.20	-1.80	-0.28	-4.57	-0.38	-1.37
Purchase of Investments	-0.01	-0.02	-0.03	-0.47	-0.01	-0.01	-0.03	-0.46	-0.01	-0.03	-0.03
Sale of Property, Plant & Equipment	0.02	0.78	0.15	0.02	0.09	0.16	0.01	0.23	0.01	0.01	6.29
Other Investing Activities, net	0.89	0.06	-	-	0.06	0.64	1.14	-	-	0.02	0.08
Net Cash From Financing Activities	-2.28	8.82	5.20	-21	-2.18	15	-4.99	6.34	6.95	15	3.86
Net Cash From Continuing Financing Activities	-2.60	8.82	5.20	-21	-2.18	15	-4.99	6.34	6.95	15	3.86
Repayment of Debt	-0.09	-26	-26	-63	-61	-24	-38	-34	-42	-21	-27
Issuance of Debt	-	38	34	44	60	41	35	43	51	38	31
Other Financing Activities, net	-1.03	-0.81	-1.39	-0.16	-0.66	-1.38	-0.52	-0.55	-0.54	-0.72	-0.32
Effect of Exchange Rate Changes	-	-0.01	-0.02	0.02	0.00	0.00	0.02	0.01	0.00	-0.36	0.25
Cash Interest Paid	0.06	0.16	0.30	0.36	0.16	0.14	0.26	0.24	0.55	0.72	0.57
Cash Income Taxes Paid	6.90	0.00	0.26	2.06	2.88	0.00	0.69	-	0.01	0.00	0.19

This table presents Limoneira's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2020	2021	2022	2023	2024	2025
Period end date	10/31/2014	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Total Assets	247	269	305	339	421	390	392	369	301	299	311
Total Current Assets	15	14	18	23	31	43	42	38	30	26	40
Cash & Equivalents	0.09	0.04	0.04	0.49	0.61	0.50	0.44	0.86	3.63	3.00	1.51
Accounts Receivable	7.24	7.42	9.30	11	14	19	23	20	19	17	18
Inventories, net	3.69	3.92	3.84	4.12	5.41	6.87	7.50	8.64	2.33	1.88	2.41
Prepaid Expenses	2.66	2.39	2.51	6.98	11	11	11	8.50	5.59	3.85	4.44
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	0.00	14
Plant, Property, & Equipment, net	106	129	177	188	226	243	242	223	161	162	173
Total Noncurrent Assets	126	127	110	128	165	104	108	108	110	111	98
Long-Term Investments	28	22	24	36	43	61	64	73	79	82	72
Goodwill	-	-	-	-	1.43	1.54	1.53	1.51	1.51	1.50	1.51
Intangible Assets	-	-	-	-	6.23	11	8.33	7.32	6.66	5.22	2.62
Other Noncurrent Operating Assets	96	105	86	92	114	30	34	27	23	23	22
Total Liabilities & Shareholders' Equity	247	269	305	339	421	390	392	369	301	299	311
Total Liabilities	116	136	167	191	191	183	193	177	101	96	120
Total Current Liabilities	21	20	24	24	27	31	35	39	33	35	30
Short-Term Debt	0.58	0.59	2.51	3.03	3.13	3.28	2.47	1.73	0.38	0.56	0.03
Accounts Payable	6.36	6.61	5.56	6.31	6.13	12	16	11	9.89	7.26	7.90
Accrued Expenses	7.54	5.86	6.42	5.18	7.72	7.95	6.54	11	8.65	12	9.29
Other Current Liabilities	6.65	6.61	9.27	9.10	10	8.13	10	16	14	15	13
Total Noncurrent Liabilities	95	116	143	168	164	152	158	137	67	62	90
Long-Term Debt	68	89	88	102	77	123	130	104	41	40	72
Noncurrent Deferred & Payable Income Tax Liabilities	21	19	25	31	25	22	23	23	22	20	15
Other Noncurrent Operating Liabilities	6.28	7.64	29	34	62	6.57	4.50	9.81	4.56	1.40	2.38
Commitments & Contingencies	0.00	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	12	12	12	11	11	11	11	11	11	11	11
Total Equity & Noncontrolling Interests	118	121	126	137	219	196	188	181	190	192	180
Total Preferred & Common Equity	118	121	126	137	219	182	176	169	178	181	161
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	118	121	126	136	219	182	176	169	178	181	161
Common Stock	90	91	92	94	159	162	164	165	169	170	172
Retained Earnings	23	27	32	35	50	31	22	16	19	21	-1.07
Treasury Stock	-	-	-	-	-	-3.49	-3.49	-3.49	-3.49	-3.49	-3.49
Accumulated Other Comprehensive Income / (Loss)	5.11	3.16	2.70	7.08	8.97	-7.55	-5.73	-7.91	-5.67	-6.61	-6.27
Noncontrolling Interest	-	-	0.00	0.59	0.57	14	12	12	11	11	19

This table presents Limoneira's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	1/31/2023	4/30/2023	7/31/2023	1/31/2024	4/30/2024	7/31/2024	1/31/2025	4/30/2025	7/31/2025	1/31/2026	4/30/2026
Total Assets	321	316	313	300	322	307	301	297	300	308	294
Total Current Assets	42	45	43	29	35	35	28	30	46	26	41
Cash & Equivalents	12	9.83	11	0.53	1.40	1.09	1.13	2.08	2.11	1.27	0.89
Accounts Receivable	21	21	23	20	25	25	20	20	24	13	14
Inventories, net	2.90	2.74	2.62	2.58	3.43	3.30	2.12	3.04	3.40	1.78	3.53
Prepaid Expenses	5.43	12	6.12	5.49	4.54	5.59	5.30	4.93	3.87	9.72	4.96
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	13	0.00	18
Plant, Property, & Equipment, net	172	164	163	160	161	162	164	165	154	174	141
Total Noncurrent Assets	108	107	107	111	127	110	109	102	100	108	112
Long-Term Investments	73	73	73	79	96	80	82	74	74	73	74
Goodwill	1.53	1.53	1.52	1.51	1.51	1.51	1.50	1.51	1.50	1.37	1.37
Intangible Assets	7.42	7.24	7.00	6.42	6.21	5.39	4.80	4.72	2.77	2.44	2.33
Other Noncurrent Operating Assets	25	25	25	24	23	23	21	21	21	32	34
Total Liabilities & Shareholders' Equity	321	316	313	300	322	307	301	297	300	308	294
Total Liabilities	110	108	106	105	122	102	104	103	109	127	130
Total Current Liabilities	39	38	37	31	38	38	27	29	26	22	25
Short-Term Debt	0.45	0.45	0.44	0.67	0.63	0.59	0.10	0.07	0.04	0.03	0.41
Accounts Payable	15	14	8.99	8.77	9.93	7.42	10	9.12	7.75	6.52	7.07
Accrued Expenses	11	7.94	8.39	8.08	11	13	9.20	7.95	7.51	6.63	7.43
Other Current Liabilities	4.24	8.11	12	13	16	18	7.81	11	10	9.21	9.77
Total Noncurrent Liabilities	72	69	69	74	85	63	77	75	83	104	105
Long-Term Debt	41	41	41	51	60	40	58	55	63	90	94
Noncurrent Deferred & Payable Income Tax Liabilities	24	22	22	18	21	21	18	18	18	13	7.11
Other Noncurrent Operating Liabilities	7.10	6.67	6.08	4.22	4.02	2.35	1.25	1.75	1.54	2.02	4.61
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	11	11	11	11	11	11	11	11	11	11	11
Total Equity & Noncontrolling Interests	200	198	195	184	189	195	187	183	180	170	153
Total Preferred & Common Equity	189	186	184	173	178	184	176	172	170	150	135
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	189	186	184	173	178	184	176	172	170	150	135
Common Stock	166	167	168	169	169	170	170	171	171	171	172
Retained Earnings	30	27	24	14	19	24	16	11	9.10	-12	-33
Treasury Stock	-3.49	-3.49	-3.49	-3.49	-3.49	-3.49	-3.49	-3.49	-3.49	-3.49	-3.49
Accumulated Other Comprehensive Income / (Loss)	-3.96	-4.01	-4.50	-6.13	-6.37	-6.38	-6.88	-6.38	-6.79	-5.49	-0.31
Noncontrolling Interest	11	11	11	11	11	11	11	11	10	19	18

This table displays calculated financial ratios and metrics derived from Limoneira's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
DEI Shares Outstanding	14,128,830.00	14,178,226.00	14,405,031.00	17,669,314.00	17,772,753.00	17,815,607.00	17,685,400.00	-	-	-	18,048,294.00
DEI Adjusted Shares Outstanding	14,128,830.00	14,178,226.00	14,405,031.00	17,669,314.00	17,772,753.00	17,815,607.00	17,685,400.00	-	-	-	18,048,294.00
DEI Earnings Per Adjusted Shares Outstanding	0.46	0.52	0.42	1.11	-0.36	-0.95	-0.22	-	-	-	-0.91
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.05%	11.44%	8.52%	6.66%	32.46%	-3.99%	0.89%	11.19%	-2.55%	6.45%	-16.60%
EBITDA Growth	10.08%	28.28%	-2.96%	12.61%	-94.69%	-1,425.46%	123.80%	209.53%	51.65%	-85.62%	-561.09%
EBIT Growth	7.03%	28.64%	-12.38%	13.49%	-153.50%	-234.42%	75.11%	119.96%	555.86%	-173.01%	-240.46%
NOPAT Growth	-55.16%	89.27%	31.59%	94.49%	-127.14%	-244.72%	66.68%	32.57%	346.08%	-152.18%	-272.13%
Net Income Growth	1.30%	13.78%	-18.73%	208.63%	-127.04%	-228.23%	78.28%	87.84%	2,023.42%	-21.31%	-327.99%
EPS Growth	0.00%	13.04%	-19.23%	197.62%	-129.60%	-159.46%	76.04%	82.61%	1,350.00%	-20.00%	-332.50%
Operating Cash Flow Growth	-52.18%	85.89%	29.21%	-0.46%	-92.58%	-929.08%	184.87%	54.40%	-207.01%	212.50%	-133.66%
Free Cash Flow Firm Growth	-229.14%	106.57%	-285.66%	-972.14%	777.97%	-208.71%	99.52%	3,250.23%	77.93%	-104.61%	-851.19%
Invested Capital Growth	17.90%	1.85%	5.20%	23.34%	-93.58%	1,481.76%	-1.16%	-16.30%	-28.98%	-0.32%	10.96%
Revenue Q/Q Growth	-2.04%	5.00%	-26.62%	-46.01%	95,121.11%	-3.91%	2.29%	3.45%	1.00%	1.28%	-0.65%
EBITDA Q/Q Growth	63.09%	-3.39%	-17.59%	-3.43%	309.06%	-56.58%	422.40%	47.19%	-29.55%	153.06%	-231.43%
EBIT Q/Q Growth	103.58%	-6.65%	-25.79%	-7.75%	16.02%	-29.09%	33.21%	155.35%	-45.15%	53.67%	-68.45%
NOPAT Q/Q Growth	-7.21%	75.60%	-20.31%	-36.02%	52.00%	-45.19%	32.66%	-80.72%	-40.51%	56.20%	-69.03%
Net Income Q/Q Growth	97.11%	-7.30%	-29.02%	-2.69%	0.07%	-31.70%	42.39%	80.03%	-7.81%	29.10%	-76.40%
EPS Q/Q Growth	119.05%	-3.70%	-32.26%	-6.72%	19.57%	-33.33%	37.84%	77.78%	-5.66%	25.00%	-75.47%
Operating Cash Flow Q/Q Growth	-9.50%	70.71%	-21.54%	-14.68%	356.58%	20.88%	-43.10%	298.44%	-82.90%	123.61%	-1,550.82%
Free Cash Flow Firm Q/Q Growth	-13.89%	115.27%	-186.33%	-20.54%	1,753.10%	-1,252.84%	-110.32%	1,830.94%	-35.98%	68.88%	-279.08%
Invested Capital Q/Q Growth	5.10%	-0.75%	1.83%	0.77%	-93.69%	-3.95%	1.83%	-14.99%	-2.38%	-3.83%	6.77%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.05%	23.37%	24.62%	24.20%	11.10%	4.42%	10.56%	12.98%	5.97%	13.94%	3.08%
EBITDA Margin	15.14%	17.43%	15.59%	16.46%	0.66%	-9.11%	2.15%	5.98%	9.31%	1.26%	-6.95%
Operating Margin	4.57%	8.22%	9.78%	7.33%	-3.22%	-11.55%	-3.81%	1.19%	5.99%	-3.23%	-12.78%
EBIT Margin	10.93%	12.61%	10.18%	10.84%	-4.38%	-15.25%	-3.76%	0.68%	4.54%	-3.12%	-12.72%
Profit (Net Income) Margin	7.06%	7.21%	5.40%	15.62%	-3.19%	-10.90%	-2.35%	-0.26%	5.07%	3.75%	-10.24%
Tax Burden Percent	64.06%	60.47%	61.63%	149.91%	83.29%	67.87%	93.61%	-135.82%	68.22%	62.13%	77.87%
Interest Burden Percent	100.87%	94.50%	86.01%	96.16%	87.48%	105.37%	66.67%	28.01%	163.53%	-193.55%	103.41%
Effective Tax Rate	35.94%	39.53%	38.37%	-49.91%	0.00%	0.00%	0.00%	235.82%	31.78%	37.87%	0.00%
Return on Invested Capital (ROIC)	1.58%	2.73%	3.47%	5.89%	-2.72%	-9.25%	-1.65%	-1.22%	3.84%	-2.42%	-8.54%
ROIC Less NNEP Spread (ROIC-NNEP)	9.22%	6.44%	2.34%	17.37%	-0.81%	-2.64%	-0.84%	3.79%	-33.85%	-28.21%	-1.50%
Return on Net Nonoperating Assets (RNNOA)	3.79%	3.19%	1.10%	4.80%	0.30%	0.87%	-0.27%	0.97%	0.81%	5.98%	0.22%
Return on Equity (ROE)	5.36%	5.92%	4.57%	10.69%	-2.42%	-8.38%	-1.92%	-0.24%	4.65%	3.56%	-8.32%
Cash Return on Invested Capital (CROIC)	-14.85%	0.89%	-1.60%	-15.01%	173.14%	-185.46%	-0.48%	16.52%	37.73%	-2.10%	-18.93%
Operating Return on Assets (OROA)	4.25%	4.91%	3.83%	3.69%	-1.83%	-6.36%	-1.60%	0.33%	2.44%	-1.99%	-6.66%
Return on Assets (ROA)	2.74%	2.80%	2.03%	5.32%	-1.33%	-4.55%	-1.00%	-0.12%	2.72%	2.39%	-5.36%
Return on Common Equity (ROCE)	4.86%	5.39%	4.18%	10.03%	-1.17%	-3.56%	-1.70%	-0.21%	4.12%	3.18%	-7.23%
Return on Equity Simple (ROE_SIMPLE)	5.84%	6.37%	4.79%	9.25%	0.00%	-9.86%	-2.21%	-0.28%	5.11%	3.96%	0.00%
Net Operating Profit after Tax (NOPAT)	2.94	5.56	7.31	14	-3.86	-13	-4.43	-2.99	7.36	-3.84	-14
NOPAT Margin	2.93%	4.97%	6.03%	10.99%	-2.25%	-8.09%	-2.67%	-1.62%	4.09%	-2.00%	-8.94%
Net Nonoperating Expense Percent (NNEP)	-7.65%	-3.71%	1.13%	-11.48%	-1.91%	-6.60%	-0.81%	-5.01%	37.70%	25.79%	-7.04%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-1.04%	3.19%	-1.65%	-5.66%
Cost of Revenue to Revenue	76.95%	76.63%	75.38%	75.80%	88.90%	95.58%	89.44%	87.02%	94.03%	86.06%	96.92%
SG&A Expenses to Revenue	13.73%	11.91%	11.50%	12.41%	12.35%	12.93%	11.70%	11.82%	14.71%	14.34%	15.32%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	18.48%	15.15%	14.84%	16.87%	14.32%	15.97%	14.38%	11.78%	-0.03%	17.17%	15.85%
Earnings before Interest and Taxes (EBIT)	11	14	12	14	-7.50	-25	-6.24	1.25	8.17	-5.97	-20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	15	19	19	21	1.13	-15	3.57	11	17	2.41	-11
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.61	1.94	2.20	1.79	1.49	1.26	1.53	1.21	1.42	2.56	1.59
Price to Tangible Book Value (P/TBV)	1.61	1.94	2.20	1.86	1.60	1.36	1.62	1.27	1.49	2.65	1.63
Price to Revenue (P/Rev)	1.94	2.20	2.47	3.03	1.79	1.39	1.63	1.11	1.41	2.42	1.60
Price to Earnings (P/E)	30.25	33.10	49.61	19.89	0.00	0.00	0.00	0.00	28.47	64.15	0.00
Dividend Yield	1.30%	1.15%	1.06%	1.13%	1.74%	2.33%	1.96%	2.60%	2.13%	1.17%	2.12%
Earnings Yield	3.31%	3.02%	2.02%	5.03%	0.00%	0.00%	0.00%	0.00%	3.51%	1.56%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.37	1.58	1.76	1.65	20.75	1.18	1.35	1.16	1.47	2.78	1.61
Enterprise Value to Revenue (EV/Rev)	2.75	2.91	3.13	3.40	2.07	1.93	2.18	1.40	1.30	2.30	1.78
Enterprise Value to EBITDA (EV/EBITDA)	18.13	16.67	20.05	20.64	313.99	0.00	101.34	23.43	13.97	182.83	0.00
Enterprise Value to EBIT (EV/EBIT)	25.12	23.04	30.69	31.35	0.00	0.00	0.00	207.68	28.62	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	93.81	58.46	51.87	30.91	0.00	0.00	0.00	0.00	31.80	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	35.79	22.71	20.52	23.89	260.16	0.00	37.65	17.45	0.00	24.66	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	178.55	0.00	0.00	1.45	0.00	0.00	6.37	3.24	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.67	0.65	0.71	0.35	0.49	0.61	0.67	0.55	0.20	0.20	0.38
Long-Term Debt to Equity	0.67	0.64	0.69	0.33	0.48	0.59	0.65	0.54	0.20	0.20	0.38
Financial Leverage	0.41	0.49	0.47	0.28	-0.37	-0.33	0.33	0.26	-0.02	-0.21	-0.15
Leverage Ratio	1.95	2.11	2.25	2.01	1.82	1.84	1.93	1.95	1.71	1.49	1.55
Compound Leverage Factor	1.97	2.00	1.93	1.93	1.59	1.94	1.28	0.54	2.79	-2.88	1.60
Debt to Total Capital	40.17%	39.53%	41.50%	25.83%	32.94%	37.86%	40.00%	35.55%	16.98%	16.70%	27.53%
Short-Term Debt to Total Capital	0.26%	1.09%	1.20%	1.01%	0.91%	0.99%	0.74%	0.58%	0.16%	0.23%	0.01%
Long-Term Debt to Total Capital	39.91%	38.43%	40.30%	24.82%	32.03%	36.87%	39.25%	34.96%	16.82%	16.47%	27.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	5.50%	5.33%	4.50%	3.67%	4.66%	7.39%	6.86%	7.53%	9.12%	8.79%	11.44%
Common Equity to Total Capital	54.33%	55.14%	53.77%	70.50%	0.00%	54.76%	53.14%	56.92%	73.90%	74.52%	61.03%
Debt to EBITDA	5.90	4.65	5.56	3.76	96.30	-8.39	37.23	9.58	2.45	16.86	-6.53
Net Debt to EBITDA	4.48	3.42	3.62	1.72	28.94	-4.28	19.15	2.91	-2.47	-18.25	0.11
Long-Term Debt to EBITDA	5.86	4.52	5.40	3.61	93.63	-8.18	36.53	9.42	2.43	16.62	-6.53
Debt to NOPAT	30.54	16.32	14.38	5.63	-28.22	-9.46	-29.96	-35.40	5.57	-10.58	-5.07
Net Debt to NOPAT	23.19	11.99	9.36	2.57	-8.48	-4.82	-15.41	-10.74	-5.63	11.45	0.08
Long-Term Debt to NOPAT	30.34	15.87	13.96	5.41	-27.43	-9.21	-29.40	-34.82	5.52	-10.43	-5.07
Altman Z-Score	1.48	1.53	1.56	1.82	1.66	1.11	1.31	1.26	2.27	3.52	1.61
Noncontrolling Interest Sharing Ratio	9.32%	9.00%	8.44%	6.18%	51.61%	57.50%	11.66%	11.56%	11.33%	10.76%	13.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.70	0.78	0.98	1.15	1.11	1.35	1.19	0.96	0.91	0.74	1.35
Quick Ratio	0.38	0.39	0.48	0.54	0.59	0.61	0.68	0.52	0.67	0.58	0.66
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-28	1.82	-3.38	-36	246	-267	-1.29	41	72	-3.33	-32
Operating Cash Flow to CapEx	26.96%	88.01%	143.26%	149.21%	15.16%	-260.88%	98.87%	0.00%	0.00%	213.30%	-45.78%
Free Cash Flow to Firm to Interest Expense	-187.01	1.29	-1.90	-27.37	104.87	-130.32	-0.86	17.73	146.27	-3.46	-20.39
Operating Cash Flow to Interest Expense	51.99	10.15	10.39	13.91	0.58	-5.53	6.40	6.47	-32.13	18.58	-3.87
Operating Cash Flow Less CapEx to Interest Expense	-140.86	-1.38	3.14	4.59	-3.26	-7.64	-0.07	13.94	151.71	9.87	-12.32
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.39	0.39	0.38	0.34	0.42	0.42	0.42	0.49	0.54	0.64	0.52
Accounts Receivable Turnover	13.69	13.37	11.98	10.32	10.64	8.98	7.91	8.59	9.42	10.70	8.99
Inventory Turnover	20.29	22.08	22.95	20.57	24.12	22.33	20.67	19.90	30.82	78.27	72.29
Fixed Asset Turnover	0.85	0.73	0.66	0.63	0.00	0.00	0.68	0.79	0.94	1.19	0.95
Accounts Payable Turnover	11.90	14.08	15.41	15.76	25.37	17.48	10.59	12.08	16.46	19.22	20.43
Days Sales Outstanding (DSO)	26.66	27.29	30.47	35.36	34.30	40.65	46.16	42.49	38.76	34.11	40.60
Days Inventory Outstanding (DIO)	17.99	16.53	15.90	17.75	15.13	16.35	17.65	18.34	11.84	4.66	5.05
Days Payable Outstanding (DPO)	30.68	25.92	23.68	23.16	14.39	20.88	34.47	30.22	22.17	18.99	17.87
Cash Conversion Cycle (CCC)	13.97	17.91	22.69	29.95	35.05	36.12	29.34	30.61	28.43	19.78	27.78
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	202	205	216	266	17	271	268	224	159	159	176
Invested Capital Turnover	0.54	0.55	0.58	0.54	1.21	1.14	0.62	0.75	0.94	1.21	0.96
Increase / (Decrease) in Invested Capital	31	3.74	11	50	-249	254	-3.14	-44	-65	-0.51	17
Enterprise Value (EV)	275	325	379	440	355	318	362	259	234	440	284
Market Capitalization	195	246	299	392	307	230	270	204	253	463	255
Book Value per Share	$8.58	$8.92	$9.46	$12.37	$0.00	$10.22	$9.98	$9.56	$9.93	$10.03	$8.90
Tangible Book Value per Share	$8.58	$8.92	$9.46	$11.94	$0.00	$9.50	$9.42	$9.06	$9.47	$9.66	$8.68
Total Capital	223	229	253	310	331	332	332	298	242	243	263
Total Debt	90	91	105	80	109	126	133	106	41	41	72
Total Long-Term Debt	89	88	102	77	106	123	130	104	41	40	72
Net Debt	68	67	68	37	33	64	68	32	-41	-44	-1.20
Capital Expenditures (CapEx)	29	16	13	12	9.00	4.34	9.72	-17	-91	8.37	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-5.36	-2.78	2.04	6.49	5.81	14	8.80	-0.86	-6.38	-11	8.91
Debt-free Net Working Capital (DFNWC)	-5.32	-2.74	2.54	7.10	6.43	14	9.24	-0.01	-2.75	-8.40	10
Net Working Capital (NWC)	-5.91	-5.25	-0.49	3.97	3.41	11	6.77	-1.74	-3.13	-8.96	10
Net Nonoperating Expense (NNE)	-4.15	-2.50	0.76	-5.99	1.61	4.64	-0.54	-2.52	-1.76	-11	2.07
Net Nonoperating Obligations (NNO)	68	67	68	37	-205	64	68	32	-41	-44	-15
Total Depreciation and Amortization (D&A)	4.23	5.39	6.56	7.28	8.63	10	9.81	9.80	8.58	8.37	9.21
Debt-free, Cash-free Net Working Capital to Revenue	-5.34%	-2.49%	1.69%	5.01%	3.39%	8.41%	5.30%	-0.47%	-3.55%	-5.95%	5.58%
Debt-free Net Working Capital to Revenue	-5.30%	-2.45%	2.09%	5.48%	3.75%	8.71%	5.56%	0.00%	-1.53%	-4.39%	6.53%
Net Working Capital to Revenue	-5.89%	-4.70%	-0.41%	3.07%	1.99%	6.72%	4.07%	-0.94%	-1.74%	-4.68%	6.51%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.46	$0.52	$0.42	$1.26	($0.37)	($0.96)	($0.23)	($0.04)	$0.50	$0.40	($0.93)
Adjusted Weighted Average Basic Shares Outstanding	14.12M	14.17M	14.32M	15.58M	17.58M	17.67M	17.56M	17.51M	17.60M	17.72M	17.83M
Adjusted Diluted Earnings per Share	$0.46	$0.52	$0.42	$1.25	($0.37)	($0.96)	($0.23)	($0.04)	$0.50	$0.40	($0.93)
Adjusted Weighted Average Diluted Shares Outstanding	14.12M	14.17M	14.32M	16.21M	17.58M	17.67M	17.56M	17.51M	17.60M	17.72M	17.83M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$1.26	($0.37)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	14.15M	14.22M	14.52M	17.76M	17.84M	17.65M	17.70M	17.68M	17.99M	18.08M	18.12M
Normalized Net Operating Profit after Tax (NOPAT)	2.94	5.56	7.39	7.73	-4.61	-13	-4.36	-1.61	-14	-3.75	-14
Normalized NOPAT Margin	2.93%	4.97%	6.09%	5.97%	-2.69%	-7.87%	-2.62%	-0.87%	-7.71%	-1.96%	-8.63%
Pre Tax Income Margin	11.02%	11.92%	8.76%	10.42%	-3.83%	-16.06%	-2.51%	0.19%	7.43%	6.03%	-13.15%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	74.06	10.01	6.95	10.60	-3.20	-12.25	-4.16	0.54	16.54	-6.21	-13.08
NOPAT to Interest Expense	19.84	3.94	4.11	10.75	-1.65	-6.50	-2.95	-1.30	14.89	-3.99	-9.20
EBIT Less CapEx to Interest Expense	-118.79	-1.53	-0.31	1.28	-7.05	-14.37	-10.63	8.01	200.38	-14.92	-21.53
NOPAT Less CapEx to Interest Expense	-173.02	-7.59	-3.14	1.43	-5.49	-8.62	-9.43	6.16	198.73	-12.70	-17.65
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	44.82%	42.96%	56.73%	22.39%	-106.70%	-32.65%	-148.94%	-1,227.00%	64.53%	82.34%	-36.16%
Augmented Payout Ratio	44.82%	42.96%	56.73%	22.39%	-106.70%	-52.12%	-148.94%	-1,227.00%	64.53%	82.34%	-36.16%

This table displays calculated financial ratios and metrics derived from Limoneira's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	18,045,169.00	18,069,029.00	18,048,294.00	18,119,117.00	18,106,877.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	18,045,169.00	18,069,029.00	18,048,294.00	18,119,117.00	18,106,877.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-0.19	-0.05	-0.49	-0.53	-1.18
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.48%	4.83%	-7.21%	20.59%	5.86%	-13.66%	-21.27%	-25.00%	-2.37%	-46.93%	-31.87%
EBITDA Growth	-1,207.22%	-122.03%	-46.97%	4,258.04%	91.30%	41.41%	48.23%	-83.24%	-1,171.15%	-178.88%	-1,911.37%
EBIT Growth	-228.15%	-133.19%	-22.28%	610.09%	71.44%	30.92%	25.41%	-106.89%	-298.73%	-113.95%	-701.62%
NOPAT Growth	-413.51%	-130.15%	3.75%	658.25%	71.61%	30.97%	10.01%	-107.29%	-302.91%	-97.36%	-548.55%
Net Income Growth	-27.92%	-123.67%	502.15%	597.28%	45.72%	16.48%	-151.33%	-114.74%	-368.96%	-203.26%	-563.42%
EPS Growth	-21.43%	-125.00%	450.00%	600.00%	47.06%	14.29%	-157.14%	-117.14%	-444.44%	-194.44%	-500.00%
Operating Cash Flow Growth	-183.92%	51.53%	-210.08%	319.49%	300.70%	-25.71%	395.24%	-112.08%	-85.70%	9.08%	-150.03%
Free Cash Flow Firm Growth	37.47%	-105.32%	-98.70%	-95.85%	-102.44%	-31.16%	-1,056.20%	-108.30%	-1,675.36%	-270.72%	32.74%
Invested Capital Growth	-28.98%	0.66%	-2.30%	1.19%	-0.32%	2.88%	5.83%	-0.06%	10.96%	14.13%	-4.20%
Revenue Q/Q Growth	-21.08%	-4.11%	12.27%	41.92%	-30.71%	-21.79%	2.37%	35.19%	-9.81%	-57.49%	31.43%
EBITDA Q/Q Growth	-3,083.53%	25.54%	58.02%	567.33%	-105.96%	-401.36%	62.91%	251.26%	-551.93%	-9.99%	-167.50%
EBIT Q/Q Growth	-448.41%	20.17%	42.02%	300.94%	-130.71%	-93.09%	37.39%	81.44%	-1,676.94%	-3.60%	-134.57%
NOPAT Q/Q Growth	-525.56%	20.07%	52.00%	332.63%	-131.81%	-94.33%	37.43%	81.17%	-1,659.37%	4.81%	-105.61%
Net Income Q/Q Growth	-182.96%	-3.96%	278.27%	-5.17%	-130.89%	-59.95%	-9.57%	72.78%	-882.97%	-3.43%	-139.71%
EPS Q/Q Growth	-142.86%	-23.53%	266.67%	0.00%	-125.71%	-100.00%	-11.11%	70.00%	-716.67%	-8.16%	-126.42%
Operating Cash Flow Q/Q Growth	-156.05%	-212.95%	70.56%	912.20%	-73.18%	-296.02%	169.15%	-133.23%	131.75%	-1,346.18%	61.95%
Free Cash Flow Firm Q/Q Growth	-41.54%	-111.23%	118.95%	233.17%	-134.35%	-504.73%	-38.15%	97.11%	-7,249.06%	-26.28%	74.94%
Invested Capital Q/Q Growth	-2.38%	5.30%	-2.79%	1.26%	-3.83%	8.68%	0.00%	-4.37%	6.77%	11.79%	-16.06%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	-3.53%	1.55%	9.35%	28.23%	9.21%	2.35%	9.72%	11.43%	-11.06%	-26.44%	3.21%
EBITDA Margin	-18.36%	-14.26%	-5.33%	17.55%	-1.51%	-9.68%	-3.51%	3.92%	-19.65%	-50.84%	-103.49%
Operating Margin	-23.39%	-19.49%	-10.48%	14.21%	-6.27%	-15.58%	-9.52%	-1.33%	-25.88%	-57.96%	-90.67%
EBIT Margin	-23.35%	-19.44%	-10.04%	14.21%	-6.30%	-15.55%	-9.51%	-1.31%	-25.73%	-62.70%	-111.90%
Profit (Net Income) Margin	-8.54%	-9.25%	14.70%	9.82%	-4.38%	-8.95%	-9.58%	-1.93%	-21.03%	-51.16%	-93.30%
Tax Burden Percent	73.28%	46.74%	55.66%	67.31%	120.15%	56.06%	109.82%	124.80%	76.77%	77.55%	80.87%
Interest Burden Percent	49.90%	101.86%	-263.00%	102.63%	57.84%	102.68%	91.74%	118.39%	106.46%	105.21%	103.10%
Effective Tax Rate	0.00%	0.00%	44.34%	32.69%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-15.38%	-14.85%	-6.31%	11.03%	-5.29%	-11.95%	-7.03%	-0.91%	-17.31%	-31.58%	-49.83%
ROIC Less NNEP Spread (ROIC-NNEP)	-84.87%	-19.70%	-29.51%	10.64%	-5.31%	-14.50%	-3.50%	0.51%	-13.07%	11.13%	22.23%
Return on Net Nonoperating Assets (RNNOA)	2.02%	3.49%	5.70%	-2.17%	1.12%	1.94%	0.52%	-0.09%	1.96%	-0.27%	-1.23%
Return on Equity (ROE)	-13.36%	-11.36%	-0.61%	8.86%	-4.17%	-10.00%	-6.51%	-0.99%	-15.35%	-31.85%	-51.06%
Cash Return on Invested Capital (CROIC)	37.73%	-10.24%	-7.72%	-6.53%	-2.10%	-4.08%	-6.68%	-5.07%	-18.93%	-22.92%	-13.95%
Operating Return on Assets (OROA)	-12.54%	-11.38%	-5.61%	8.67%	-4.02%	-9.63%	-5.43%	-0.69%	-13.47%	-29.58%	-50.19%
Return on Assets (ROA)	-4.59%	-5.42%	8.21%	5.99%	-2.79%	-5.54%	-5.47%	-1.02%	-11.01%	-24.13%	-41.85%
Return on Common Equity (ROCE)	-11.85%	-10.13%	-0.54%	7.92%	-3.72%	-8.90%	-5.79%	-0.89%	-13.34%	-27.51%	-43.84%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-5.83%	-1.07%	3.02%	0.00%	4.42%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-6.78	-5.42	-2.60	6.05	-1.93	-3.74	-2.34	-0.44	-7.76	-7.39	-15
NOPAT Margin	-16.37%	-13.65%	-5.83%	9.56%	-4.39%	-10.91%	-6.67%	-0.93%	-18.12%	-40.57%	-63.47%
Net Nonoperating Expense Percent (NNEP)	69.49%	4.85%	23.20%	0.39%	0.01%	2.55%	-3.52%	-1.41%	-4.23%	-42.72%	-72.06%
Return On Investment Capital (ROIC_SIMPLE)	-2.94%	-2.29%	-	-	-0.83%	-1.53%	-0.99%	-0.18%	-3.07%	-2.84%	-6.15%
Cost of Revenue to Revenue	103.53%	98.45%	90.65%	71.77%	90.79%	97.65%	90.28%	88.57%	111.06%	126.44%	96.79%
SG&A Expenses to Revenue	15.80%	18.49%	16.52%	11.05%	13.13%	18.87%	16.32%	10.44%	17.07%	25.23%	22.65%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	19.86%	21.05%	19.83%	14.02%	15.49%	17.93%	19.25%	12.76%	14.82%	31.51%	93.88%
Earnings before Interest and Taxes (EBIT)	-9.67	-7.72	-4.48	9.00	-2.76	-5.34	-3.34	-0.62	-11	-11	-27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-7.61	-5.67	-2.38	11	-0.66	-3.32	-1.23	1.86	-8.42	-9.26	-25
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.42	1.86	1.99	2.15	2.56	2.37	1.55	1.56	1.59	1.73	1.71
Price to Tangible Book Value (P/TBV)	1.49	1.95	2.08	2.24	2.65	2.46	1.61	1.60	1.63	1.78	1.76
Price to Revenue (P/Rev)	1.41	1.77	1.99	2.10	2.42	2.24	1.51	1.65	1.60	1.82	1.74
Price to Earnings (P/E)	28.47	0.00	0.00	70.65	64.15	53.97	0.00	0.00	0.00	0.00	0.00
Dividend Yield	2.13%	1.68%	1.52%	1.36%	1.17%	1.30%	2.03%	2.04%	2.12%	2.08%	2.36%
Earnings Yield	3.51%	0.00%	0.00%	1.42%	1.56%	1.85%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.47	1.89	2.09	2.29	2.78	2.40	1.55	1.66	1.61	1.56	1.69
Enterprise Value to Revenue (EV/Rev)	1.30	1.74	1.91	2.00	2.30	2.22	1.51	1.70	1.78	2.14	2.11
Enterprise Value to EBITDA (EV/EBITDA)	13.97	0.00	0.00	0.00	182.83	86.93	45.28	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	28.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	31.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	47.30	24.66	27.17	9.84	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.20	0.27	0.30	0.20	0.20	0.29	0.28	0.33	0.38	0.50	0.57
Long-Term Debt to Equity	0.20	0.26	0.30	0.19	0.20	0.29	0.28	0.33	0.38	0.50	0.57
Financial Leverage	-0.02	-0.18	-0.19	-0.20	-0.21	-0.13	-0.15	-0.17	-0.15	-0.02	-0.06
Leverage Ratio	1.71	1.53	1.56	1.51	1.49	1.53	1.57	1.53	1.55	1.61	1.65
Compound Leverage Factor	0.85	1.56	-4.11	1.54	0.86	1.57	1.44	1.81	1.65	1.69	1.70
Debt to Total Capital	16.98%	21.08%	23.14%	16.50%	16.70%	22.70%	22.14%	24.90%	27.53%	33.24%	36.50%
Short-Term Debt to Total Capital	0.16%	0.27%	0.24%	0.24%	0.23%	0.04%	0.03%	0.02%	0.01%	0.01%	0.16%
Long-Term Debt to Total Capital	16.82%	20.81%	22.90%	16.26%	16.47%	22.67%	22.11%	24.89%	27.51%	33.23%	36.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	9.12%	8.85%	8.41%	8.72%	8.79%	8.35%	8.58%	8.35%	11.44%	11.14%	11.31%
Common Equity to Total Capital	73.90%	70.07%	68.45%	74.78%	74.52%	68.95%	69.28%	66.74%	61.03%	55.62%	52.19%
Debt to EBITDA	2.45	-3.56	-3.91	-8.96	16.86	12.19	9.32	-18.91	-6.53	-5.28	-2.32
Net Debt to EBITDA	-2.47	1.88	2.40	9.00	-18.25	-5.27	-3.59	3.90	0.11	-0.94	-0.48
Long-Term Debt to EBITDA	2.43	-3.51	-3.86	-8.83	16.62	12.17	9.31	-18.90	-6.53	-5.28	-2.31
Debt to NOPAT	5.57	-3.26	-3.63	-4.64	-10.58	-27.48	-32.08	-7.50	-5.07	-5.02	-3.06
Net Debt to NOPAT	-5.63	1.72	2.23	4.66	11.45	11.87	12.34	1.55	0.08	-0.89	-0.64
Long-Term Debt to NOPAT	5.52	-3.21	-3.59	-4.57	-10.43	-27.43	-32.04	-7.49	-5.07	-5.02	-3.05
Altman Z-Score	2.08	2.42	2.32	3.16	3.56	3.05	2.17	2.12	1.70	1.54	1.12
Noncontrolling Interest Sharing Ratio	11.33%	10.87%	10.79%	10.59%	10.76%	11.01%	10.98%	10.77%	13.09%	13.62%	14.13%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.91	0.92	0.93	0.93	0.74	1.05	1.05	1.80	1.35	1.16	1.68
Quick Ratio	0.67	0.66	0.72	0.70	0.58	0.77	0.77	1.00	0.66	0.65	0.59
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	58	-6.53	1.24	4.12	-1.42	-8.56	-12	-0.34	-25	-32	-7.95
Operating Cash Flow to CapEx	-247.51%	-704.94%	-228.74%	820.89%	253.44%	-329.39%	374.34%	-102.03%	24.07%	-389.87%	0.00%
Free Cash Flow to Firm to Interest Expense	754.78	-31.53	3.52	15.10	-10.89	-32.93	-51.88	-0.83	-38.37	-40.74	-14.21
Operating Cash Flow to Interest Expense	-42.62	-49.62	-8.62	89.97	50.67	-49.66	39.16	-7.24	1.44	-15.07	-7.98
Operating Cash Flow Less CapEx to Interest Expense	-59.84	-56.66	-12.38	79.01	30.68	-64.74	28.70	-14.33	-4.54	-18.93	-5.65
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.54	0.59	0.56	0.61	0.64	0.62	0.57	0.53	0.52	0.47	0.45
Accounts Receivable Turnover	9.42	8.85	7.67	7.75	10.70	9.33	7.81	6.54	8.99	8.67	7.90
Inventory Turnover	30.82	60.91	54.84	56.72	78.27	67.64	46.54	43.91	72.29	73.88	41.36
Fixed Asset Turnover	0.94	1.10	1.10	1.17	1.19	1.15	1.08	1.02	0.95	0.85	0.87
Accounts Payable Turnover	16.46	14.01	14.29	20.47	19.22	16.86	15.79	19.40	20.43	17.35	16.77
Days Sales Outstanding (DSO)	38.76	41.26	47.57	47.10	34.11	39.14	46.76	55.82	40.60	42.10	46.22
Days Inventory Outstanding (DIO)	11.84	5.99	6.66	6.44	4.66	5.40	7.84	8.31	5.05	4.94	8.83
Days Payable Outstanding (DPO)	22.17	26.05	25.55	17.83	18.99	21.65	23.11	18.82	17.87	21.03	21.76
Cash Conversion Cycle (CCC)	28.43	21.21	28.68	35.70	19.78	22.89	31.49	45.32	27.78	26.01	33.29
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	159	167	163	165	159	172	172	165	176	197	165
Invested Capital Turnover	0.94	1.09	1.08	1.15	1.21	1.10	1.05	0.98	0.96	0.78	0.79
Increase / (Decrease) in Invested Capital	-65	1.11	-3.84	1.93	-0.51	4.82	9.49	-0.10	17	24	-7.23
Enterprise Value (EV)	234	316	340	378	440	413	267	273	284	307	279
Market Capitalization	253	322	355	397	463	417	267	265	255	261	231
Book Value per Share	$9.93	$9.82	$9.88	$10.23	$10.03	$9.73	$9.54	$9.40	$8.90	$8.31	$7.43
Tangible Book Value per Share	$9.47	$9.37	$9.45	$9.85	$9.66	$9.39	$9.19	$9.16	$8.68	$8.10	$7.23
Total Capital	242	247	260	246	243	255	248	254	263	271	258
Total Debt	41	52	60	41	41	58	55	63	72	90	94
Total Long-Term Debt	41	51	60	40	40	58	55	63	72	90	94
Net Debt	-41	-28	-37	-41	-44	-25	-21	-13	-1.20	16	20
Capital Expenditures (CapEx)	1.33	1.46	1.32	2.99	2.60	3.92	2.39	2.91	3.91	3.01	-1.30
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-6.38	-2.21	-3.47	-3.23	-11	0.22	-0.70	18	8.91	2.37	16
Debt-free Net Working Capital (DFNWC)	-2.75	-1.69	-2.07	-2.14	-8.40	1.35	1.38	21	10	3.63	17
Net Working Capital (NWC)	-3.13	-2.35	-2.69	-2.73	-8.96	1.25	1.31	21	10	3.61	17
Net Nonoperating Expense (NNE)	-3.25	-1.74	-9.16	-0.16	-0.01	-0.67	1.02	0.48	1.25	1.93	7.14
Net Nonoperating Obligations (NNO)	-41	-28	-37	-41	-44	-25	-21	-26	-15	16	1.34
Total Depreciation and Amortization (D&A)	2.07	2.06	2.10	2.12	2.10	2.02	2.11	2.48	2.60	2.16	2.01
Debt-free, Cash-free Net Working Capital to Revenue	-3.55%	-1.22%	-1.95%	-1.71%	-5.95%	0.12%	-0.40%	11.48%	5.58%	1.65%	12.25%
Debt-free Net Working Capital to Revenue	-1.53%	-0.93%	-1.16%	-1.13%	-4.39%	0.72%	0.78%	12.79%	6.53%	2.53%	12.92%
Net Working Capital to Revenue	-1.74%	-1.30%	-1.51%	-1.44%	-4.68%	0.67%	0.74%	12.76%	6.51%	2.51%	12.62%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.20)	($0.21)	$0.36	$0.36	($0.11)	($0.18)	($0.20)	($0.06)	($0.49)	($0.53)	($1.20)
Adjusted Weighted Average Basic Shares Outstanding	17.60M	17.63M	17.71M	17.76M	17.72M	17.79M	17.83M	17.85M	17.83M	17.91M	17.93M
Adjusted Diluted Earnings per Share	($0.17)	($0.21)	$0.35	$0.35	($0.09)	($0.18)	($0.20)	($0.06)	($0.49)	($0.53)	($1.20)
Adjusted Weighted Average Diluted Shares Outstanding	17.60M	17.63M	18.36M	18.36M	17.72M	17.79M	17.83M	17.85M	17.83M	17.91M	17.93M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.99M	18.00M	18.01M	18.05M	18.08M	18.05M	18.07M	18.05M	18.12M	18.11M	18.13M
Normalized Net Operating Profit after Tax (NOPAT)	-6.54	-5.54	-2.58	6.48	-2.19	-3.75	-2.34	-0.43	-7.28	-7.33	-8.66
Normalized NOPAT Margin	-15.78%	-13.94%	-5.77%	10.23%	-4.99%	-10.92%	-6.67%	-0.91%	-17.01%	-40.29%	-36.19%
Pre Tax Income Margin	-11.65%	-19.80%	26.40%	14.59%	-3.64%	-15.97%	-8.72%	-1.55%	-27.39%	-65.97%	-115.38%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-125.64	-37.31	-12.76	32.96	-21.25	-20.52	-14.65	-1.51	-16.82	-14.65	-47.81
NOPAT to Interest Expense	-88.09	-26.19	-7.41	22.17	-14.81	-14.39	-10.27	-1.08	-11.85	-9.48	-27.12
EBIT Less CapEx to Interest Expense	-142.86	-44.35	-16.52	22.00	-41.25	-35.60	-25.11	-8.60	-22.80	-18.52	-45.48
NOPAT Less CapEx to Interest Expense	-105.31	-33.23	-11.18	11.21	-34.81	-29.47	-20.73	-8.17	-17.82	-13.35	-24.79
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	64.53%	-58.41%	-308.85%	106.19%	82.34%	75.96%	-276.40%	-63.79%	-36.16%	-26.20%	-10.69%
Augmented Payout Ratio	64.53%	-58.41%	-308.85%	106.19%	82.34%	75.96%	-276.40%	-63.79%	-36.16%	-26.20%	-10.69%

Financials Breakdown Chart

Key Financial Trends

Limoneira’s latest quarter shows a business under pressure on profitability, but with some balance sheet and financing flexibility. In Q2 2026, revenue rose modestly year over year, but the company posted a large net loss and negative operating cash flow. Compared with the prior year, the trend is still messy: revenue is lower than it was in the stronger 2024 period, margins have compressed, and debt remains a major part of the capital structure.

Q2 2026 revenue increased to $23.9 million from $18.2 million in Q1 2026, showing a sequential rebound in sales.
The company generated $6.3 million from the sale of property, plant and equipment in Q2 2026, which helped offset investing cash needs.
Long-term debt declined to $93.7 million at Q2 2026 from $89.9 million in Q1 2026? Actually, after a debt issuance/repayment mix, debt remained manageable relative to assets, and short-term debt was minimal at $408,000.
Total equity and noncontrolling interests were still sizable at $152.9 million in Q2 2026, providing a meaningful capital cushion.
Gross profit in Q2 2026 was only $768,000, so the business is operating with very thin margin buffer.
The company reported a large impairment charge in Q2 2026 of $9.3 million, which suggests ongoing asset or business-line pressure.
Cash at quarter-end was just $891,000, but working capital remained positive because of receivables, inventory, and other current assets.
The company continued to use debt markets in the quarter, with $31.2 million of debt issued and $27.0 million repaid.
Q2 2026 net income was a loss of $22.3 million, a sharp deterioration from the $9.3 million loss in Q1 2026.
Operating cash flow was negative at -$4.5 million in Q2 2026, after a much deeper -$11.7 million in Q1 2026.
The company’s operating income was deeply negative at -$21.7 million in Q2 2026, reflecting weak profitability and heavy non-core charges.
Revenue is still well below the stronger 2024 quarters, when quarterly sales were often in the $40 million to $60 million range.
A large portion of assets is tied up in PP&E and long-term investments, while retained earnings remain negative at -$33.4 million, indicating a history of accumulated losses.

Longer-term trend: Limoneira’s results have swung dramatically over the past four years. In 2023, the company had several profitable quarters, especially Q1 2023 and Q3 2024, but that strength did not hold. Since late 2024 and into 2025/2026, revenue has fallen, margins have weakened, and quarterly losses have become more common. The latest quarter suggests the company is still working through a difficult operating environment, with debt, impairment charges, and weak gross profit limiting earnings power.

Bottom line: LMNR does not currently look like a steady earnings compounder. The balance sheet is still functioning, but the income statement and cash flow statement point to a business that needs a meaningful turnaround in operating performance before investors can count on consistent profitability.

07/21/26 09:06 PM ETAI Generated. May Contain Errors.

Limoneira Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Limoneira's financial year ends in October. Their financial year 2025 ended on October 31, 2025.

Limoneira's net income appears to be on a downward trend, with a most recent value of -$16.36 million in 2025, falling from $7.08 million in 2015. The previous period was $7.17 million in 2024. See Limoneira's forecast for analyst expectations on what's next for the company.

Limoneira's total operating income in 2025 was -$20.41 million, based on the following breakdown:

Total Gross Profit: $4.91 million
Total Operating Expenses: $25.32 million

Over the last 10 years, Limoneira's total revenue changed from $100.31 million in 2015 to $159.72 million in 2025, a change of 59.2%.

Limoneira's total liabilities were at $120.30 million at the end of 2025, a 24.9% increase from 2024, and a 3.5% increase since 2014.

In the past 10 years, Limoneira's cash and equivalents has ranged from $38 thousand in 2016 to $3.63 million in 2023, and is currently $1.51 million as of their latest financial filing in 2025.

Over the last 10 years, Limoneira's book value per share changed from 8.58 in 2015 to 8.90 in 2025, a change of 3.7%.

Related Companies

Financial statements for NASDAQ:LMNR last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Limoneira (LMNR) Financials

Financials Breakdown Chart

Key Financial Trends

Limoneira Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Limoneira (LMNR) Financials

Annual Income Statements for Limoneira

Quarterly Income Statements for Limoneira

Annual Cash Flow Statements for Limoneira

Quarterly Cash Flow Statements for Limoneira

Annual Balance Sheets for Limoneira

Quarterly Balance Sheets for Limoneira

Annual Metrics And Ratios for Limoneira

Quarterly Metrics And Ratios for Limoneira

Financials Breakdown Chart

Key Financial Trends

Limoneira Financials - Frequently Asked Questions

When does Limoneira's fiscal year end?

How has Limoneira's net income changed over the last 10 years?

What is Limoneira's operating income?

How has Limoneira's revenue changed over the last 10 years?

How much debt does Limoneira have?

How much cash does Limoneira have?

How has Limoneira's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools